Together we will beat cancer

Donate
Blank Avatar

Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.

Watch our Google Hangout about testing new treatments in patients (Part 2 of 2)

This entry is part 5 of 5 in the series Google Hangouts

We explore how clinical trials are run, and hear from a patient about what it’s like taking part in a cancer clinical trial.

Read More

All women with ovarian cancer should be offered genetic testing – so why aren’t they?

Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren’t. We explore why.

Read More

From one-eyed lambs to ‘targeted’ skin cancer drugs

Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance.

Read More

Tackling hard-to-treat cancers – what, how and why?

Read about how we’re approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours.

Read More

Watch our Google Hangout about drug discovery and making new medicines (Part 1 of 2)

This entry is part 4 of 5 in the series Google Hangouts

Discussing how the idea for a new drug can come from many different avenues.

Read More

Prostate cancer trial results should mean fewer hospital trips to have radiotherapy

The results of a clinical trial testing radiotherapy doses for treating prostate cancer should be good news for men.

Read More

Stress, cancer and electromagnetic therapy – what does the evidence say?

What does the evidence say about the link between negativity, stress and cancer and electromagnetism – a treatment that made headlines this week.

Read More

Science Snaps: switching T cells on – size matters

This entry is part 15 of 30 in the series Science Snaps

After 15 years of painstaking work, a team of scientists have revealed the detailed structure of one of the molecules controlling a T cell’s fate.

Read More

Let the right ones in – boosting immunotherapy for pancreatic cancer

Research published today in Cancer Cell might open up a way through pancreatic tumours’ defences.

Read More

Tackling brain tumours, understanding immunotherapy and revealing cancer’s genetics at the end of life – accelerating progress at our Centres

We’ve announced four new awards to speed up research in our Centres, particularly for cancers where survival is still poor.

Read More